Toronto - About 20 percent of critically ill hospital patients - including many with skin and skin structure infections - treated with vancomycin are now at risk of developing nephrotoxicity, a new study shows.
The Weekly Roundup: May 29-June 2
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
WHO Calls For Caution When it Comes to Using AI For Health
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
European Commission Approves Secukinumab for Hidradenitis Suppurativa
Addressing Disparities and Ensuring Equitable Care for LGBTQIA+ Patients